Zydus Cadila’s indigenously manufactured corona vaccine ZyCoV-D was approved for emergency use on 20 August by the Drug Controller General of India (DCGI). But so far this vaccine has not been included in the corona vaccination campaign. Now the Government of India has given information about the reason for not being able to use this vaccine.
NITI Aayog member Dr VK Pal told during the press conference that Zydus Cadila’s vaccine ZyCoV-D will not be given through a conventional syringe or needle. It is administered through an applicator, which will be used for the first time in the country. “We are working on the trainers and its logistical issues,” he added.
Zydus Cadila vaccine is not administered using conventional syringe or a needle but through an applicator, which will be used for 1st time in country. We are working on the trainers & its logistic issues: Dr VK Paul, Member-Health, NITI Aayog on delay in roll out of the vaccine pic.twitter.com/3tnurSLfvu
— ANI (@ANI) October 7, 2021
The ZyCoV-D vaccine is to be used to vaccinate adolescents aged 12-18 years. This corona vaccine from Zydus Cadila is the world’s first DNA-based vaccine. The ZyCoV-D vaccine will be given in three doses. This is the second indigenous vaccine after Bharat Biotech’s Covaccine. The company has claimed that it has conducted clinical trials of this vaccine at more than 50 centers in India so far.
According to the report of a leading daily, ZyCoV-D will be a needle-free vaccine. This vaccine will be administered with a jet injector. The ZyCoV-D vaccine will be given in three doses. The second dose will be given 28 days after its first dose and the third dose will be given after 58 days. Till now Serum Institute’s Covishield, Bharat Biotech’s Covaccine, Russian Vaccine Sputnik-V, Moderna’s Vaccine and Johnson & Johnson’s Vaccine have been approved by DCGI for vaccination.